Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

Association between body mass index and hepatitis B antibody seropositivity in children

  • Kwon, Yoowon (Department of Pediatrics, CHA Bundang Medical Center, CHA University School of Medicine) ;
  • Jeong, Su Jin (Department of Pediatrics, CHA Bundang Medical Center, CHA University School of Medicine)
  • Received : 2019.05.22
  • Accepted : 2019.08.09
  • Published : 2019.11.15
Download PDF
⟨ Previous Next ⟩

Abstract

Background: The seropositivity rate of hepatitis B surface antigen (anti-HBs) antibodies is known to be ≥95% after hepatitis B virus vaccination during infancy. However, a low level or absence of anti-HBs in healthy children is discovered in many cases. Recent studies in adults reported that a reduced anti-HBs production rate is related to obesity. Purpose: To investigate whether body mass index (BMI) affects anti-HBs levels in healthy children following 3 serial dose vaccinations in infancy. Methods: We recruited 1,200 healthy volunteers aged 3, 5, 7, or 10 years from 4-day care centers and 4 elementary schools. All subjects completed a questionnaire including body weight, height, and vaccine type received. Levels of serum hepatitis B surface antigen (HBsAg) and anti-HBs in all subjects were analyzed using electrochemiluminescence immunoassay. The standardized scores (z score) for each sex and age were obtained using the lambda-mu-sigma method in the 2017 Korean National Growth Charts for children and adolescents. Results: Our subjects (n=1,200) comprised 750 males (62.5%) and 450 females (37.5%). The overall anti-HBs seropositivity rate was 57.9% (695 of 1,200). We identified significant differences in mean BMI values between seronegative and seropositive groups (17.45 vs. 16.62, respectively; P<0.001). The anti-HBs titer was significantly decreased as the BMI z score increased adjusting for age and sex (B=-15.725; standard error=5.494; P=0.004). The probability of anti-HBs seropositivity based on BMI z score was decreased to an OR of 0.820 after the control for confounding variables (95% confidence interval, 0.728-0.923; P=0.001). Conclusion: There was a significant association between anti-HBs titer and BMI z score after adjustment for age and sex. Our results indicate that BMI is a potential factor affecting anti-HBs titer in healthy children.

Keywords

References

  1. Kim YK, Cho SI, Park HS. Obesity as a related factor of poor antibody response to hepatitis B vaccine. Korean J Obes 2003;12:245-51.
  2. Simo Minana J, Gaztambide Ganuza M, Fernandez Millan P, Pena Fernandez M. Hepatitis B vaccine immunoresponsiveness in adolescents: a revaccination proposal after primary vaccination. Vaccine 1996;14:103-6. https://doi.org/10.1016/0264-410X(95)00176-2
  3. Korea Centers for Disease Control & Prevention. Seroepidemiology of hepatitis B among preschool children in Korea. Public Health Wkly Rep 2008;1:173-7.
  4. Korea Centers for Disease Control & Prevention. Achieving the regional goal of the hepatitis B control in Korea. Public Health Wkly Rep 2008;1:273-7.
  5. Ahn YO, Kim CY, Bae SH, Chang HG. Changing pattern of HBV-related diseases in Korea since after HBV vaccination. Clin Mol Hepatol 2010;16:S23-37.
  6. Zhao H, Zhou YH. Revaccination against hepatitis B in late teenagers who received vaccination during infancy: Yes or no? Hum Vaccin Immunother 2018;14:456-63. https://doi.org/10.1080/21645515.2017.1397243
  7. Seo JH. Hepatitis B surface antigen and antibody positive rates of children and adolescents in Jeju. Taehan Kan Hakhoe Chi 2003;9: 304-14.
  8. Kim YJ, Li P, Hong JM, Ryu KH, Nam E, Chang MS. A single center analysis of the positivity of hepatitis B antibody after neonatal vaccination program in Korea. J Korean Med Sci 2017;32:810-6. https://doi.org/10.3346/jkms.2017.32.5.810
  9. Van Der Meeren O, Behre U, Crasta P. Immunity to hepatitis B persists in adolescents 15-16 years of age vaccinated in infancy with three doses of hepatitis B vaccine. Vaccine 2016;34:2745-9. https://doi.org/10.1016/j.vaccine.2016.04.013
  10. Spada E, Romano L, Tosti ME, Zuccaro O, Paladini S, Chironna M, et al. Hepatitis B immunity in teenagers vaccinated as infants: an Italian 17-year follow-up study. Clin Microbiol Infect 2014;20:O680-6. https://doi.org/10.1111/1469-0691.12591
  11. Jouneghani AS, Chaleshtori MH, Khoshdel A, Kheiri S, Farrokhi E, Khalafian P, et al. Evaluation of response to hepatitis B vaccine in Iranian 6-18-year-old students. J Res Med Sci 2017;22:116. https://doi.org/10.4103/jrms.JRMS_204_17
  12. Weber DJ, Rutala WA, Samsa GP, Santimaw JE, Lemon SM. Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine. JAMA 1985;254:3187-9. https://doi.org/10.1001/jama.1985.03360220053027
  13. Kabir A, Pazouki A, Jafari M, Mokhber S, Vaziri M, Alavian SM. Comparing anti-hepatitis B antibody level in iranian obese or overweight with non-obese cases. Iran Biomed J 2017;21:197-202. https://doi.org/10.18869/acadpub.ibj.21.3.197
  14. Fan W, Chen XF, Shen C, Guo ZR, Dong C. Hepatitis B vaccine response in obesity: a meta-analysis. Vaccine 2016;34:4835-41. https://doi.org/10.1016/j.vaccine.2016.08.027
  15. Korea Centers for Disease Control and Prevention, Division of Health and Nutrition Survey; Korean Pediatric Society, Committee for School Health and Public Health Statistics; Committee for the Development of Growth Standards for Korean Children and Adolescents. 2017 Korean National Growth Charts for children and adolescents. Cheongju (Korea): Korea Centers for Disease Control and Prevention, 2017.
  16. The Korean Pediatric Society. Immunization guideline. Seoul: The Korean Pediatric Society, 2018.
  17. Young KM, Gray CM, Bekker LG. Is obesity a risk factor for vaccine non-responsiveness? PLoS One 2013;8:e82779. https://doi.org/10.1371/journal.pone.0082779
  18. Shaw FE Jr, Guess HA, Roets JM, Mohr FE, Coleman PJ, Mandel EJ, et al. Effect of anatomic injection site, age and smoking on the immune response to hepatitis B vaccination. Vaccine 1989;7:425-30. https://doi.org/10.1016/0264-410X(89)90157-6
  19. Poirier MK, Poland GA, Jacobson RM. Parameters potentially affecting interpretation of immunogenicity and efficacy data in vaccine trials: are they adequately reported? Vaccine 1996;14:25-7. https://doi.org/10.1016/0264-410X(95)00170-6
  20. Poland GA, Borrud A, Jacobson RM, McDermott K, Wollan PC, Brakke D, et al. Determination of deltoid fat pad thickness. Implications for needle length in adult immunization. JAMA 1997;277:1709-11. https://doi.org/10.1001/jama.1997.03540450065037
  21. Centers for Disease Control and Prevention (CDC). Intensive-care patients with severe novel influenza A (H1N1) virus infection - Michigan, June 2009. MMWR Morb Mortal Wkly Rep 2009;58:749-52.
  22. Eliakim A, Schwindt C, Zaldivar F, Casali P, Cooper DM. Reduced tetanus antibody titers in overweight children. Autoimmunity 2006; 39:137-41. https://doi.org/10.1080/08916930600597326
  23. Banga N, Guss P, Banga A, Rosenman KD. Incidence and variables associated with inadequate antibody titers after pre-exposure rabies vaccination among veterinary medical students. Vaccine 2014;32: 979-83. https://doi.org/10.1016/j.vaccine.2013.12.019
  24. Karlsson EA, Beck MA. The burden of obesity on infectious disease. Exp Biol Med (Maywood) 2010;235:1412-24. https://doi.org/10.1258/ebm.2010.010227
  25. Painter SD, Ovsyannikova IG, Poland GA. The weight of obesity on the human immune response to vaccination. Vaccine 2015;33:4422-9. https://doi.org/10.1016/j.vaccine.2015.06.101
  26. Milner JJ, Beck MA. The impact of obesity on the immune response to infection. Proc Nutr Soc 2012;71:298-306. https://doi.org/10.1017/S0029665112000158

Cited by

  1. Serum YKL-40 Levels Are Associated with the Atherogenic Index of Plasma in Children vol.2020, 2019, https://doi.org/10.1155/2020/8713908
  2. Seroprevalence of anti-HBs antibodies and the need for booster vaccination in children under 5 years of age born to HBsAg-negative mothers vol.14, pp.9, 2019, https://doi.org/10.4103/1995-7645.326255
  3. Breastmilk Feeding during the First 4 to 6 Months of Age and Childhood Disease Burden until 10 Years of Age vol.13, pp.8, 2019, https://doi.org/10.3390/nu13082825
  4. Cohort profile: National Investigation of Birth Cohort in Korea study 2008 (NICKs-2008) vol.64, pp.9, 2019, https://doi.org/10.3345/cep.2020.01284
  5. Is High Milk Intake Good for Children’s Health? A National Population-Based Observational Cohort Study vol.13, pp.10, 2019, https://doi.org/10.3390/nu13103494